Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction - PubMed (original) (raw)

Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction

Luisa De Gennaro et al. Inflammation. 2012 Feb.

Abstract

Several lines of evidence indicate that increased inflammatory cytokine levels can be used for risk prediction in patients with acute coronary syndrome (ACS). This study therefore aimed to evaluate correlations between levels of soluble interleukin (IL)-2 receptor (sIL-2r), IL-6, and IL-8 and in-hospital incidence of acute heart failure (AHF) and left ventricular (LV) systolic dysfunction in the subacute phase of ACS. In 48 consecutive patients with ACS, circulating levels of sIL-2r, IL-6, and IL-8 were ascertained 72-96 h after onset of symptoms. Clinical data, LV function, and in-hospital incidence of AHF were also evaluated. IL-8 levels were significantly higher in patients with pulmonary edema (1,829 ± 2,496 vs 456 ± 624 pg/ml, p < 0.05); sIL-2r, IL-6, and IL-8 levels were increased proportionally to Killip class (r = 0.35, p < 0.05; r = 0.48, r = 0.47, p < 0.01) and in patients with LV ejection fraction (LVEF) < 30%. Levels of sIL-2r were inversely related to LVEF in subjects with acute myocardial infarction (r = -0.51, p < 0.05). Soluble IL-2r and IL-8 levels were related to mitral regurgitation severity (r = 0.34, p < 0.05; r = 0.37, p < 0.05). Levels of sIL-2 were proportional to LV end-diastolic diameter (r = 0.49, p < 0.001) and LV end-systolic diameter (r = 0.58, p < 0.001). Number of cytokines with circulating values above upper level of normal was significantly correlated with Killip class and LVEF (r = 0.40, r = -0.38, p < 0.05). sIL-2r, IL-6, and IL-8 are increased in patients with ACS and systolic dysfunction or AHF. These data suggest that inflammatory cytokine activity detectable in peripheral blood may be useful in identifying subjects with a worse clinical course.

PubMed Disclaimer

Similar articles

• Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation.
  De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A, Di Biase M. De Gennaro L, et al. Eur J Clin Invest. 2012 Apr;42(4):371-5. doi: 10.1111/j.1365-2362.2011.02592.x. Epub 2011 Sep 13. Eur J Clin Invest. 2012. PMID: 21913917
• Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
  De Gennaro L, Brunetti ND, Bungaro R, Montrone D, Cuculo A, Pellegrino PL, Correale M, Di Biase M. De Gennaro L, et al. Coron Artery Dis. 2009 Jun;20(4):274-80. doi: 10.1097/MCA.0b013e3283229d82. Coron Artery Dis. 2009. PMID: 19440066

Cited by

• The Elevated Inflammatory Status of Neutrophils Is Related to In-Hospital Complications in Patients with Acute Coronary Syndrome and Has Important Prognosis Value for Diabetic Patients.
  Barbu E, Mihaila AC, Gan AM, Ciortan L, Macarie RD, Tucureanu MM, Filippi A, Stoenescu AI, Petrea SV, Simionescu M, Balanescu SM, Butoi E. Barbu E, et al. Int J Mol Sci. 2024 May 8;25(10):5107. doi: 10.3390/ijms25105107. Int J Mol Sci. 2024. PMID: 38791147 Free PMC article.
• A comparison of opioid-containing anesthesia versus opioid-free anesthesia using the Cortínez-Sepúlveda model on differential cytokine responses in obese patients undergoing gastric bypass surgery: a randomized controlled trial.
  Campos-Pérez W, Ramírez-Plascencia L, Pérez-Robles M, Rivera-Valdés JJ, Sánchez-Muñoz P, Pérez-Vargas L, González-Landeros D, Cuevas JHM, Martínez-López E. Campos-Pérez W, et al. BMC Anesthesiol. 2022 Sep 16;22(1):294. doi: 10.1186/s12871-022-01838-8. BMC Anesthesiol. 2022. PMID: 36114460 Free PMC article. Clinical Trial.
• Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome.
  Wang C, Wu Y, Su Y, Mao B, Luo Y, Yan Y, Hu K, Lu Y, Che W, Wan M. Wang C, et al. Int J Cardiovasc Imaging. 2022 Jun;38(6):1191-1202. doi: 10.1007/s10554-022-02529-8. Epub 2022 Feb 19. Int J Cardiovasc Imaging. 2022. PMID: 35182256 Free PMC article.
• Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies.
  Gerbino A, Forleo C, Milano S, Piccapane F, Procino G, Pepe M, Piccolo M, Guida P, Resta N, Favale S, Svelto M, Carmosino M. Gerbino A, et al. J Cell Mol Med. 2021 Dec;25(23):10902-10915. doi: 10.1111/jcmm.16975. Epub 2021 Nov 12. J Cell Mol Med. 2021. PMID: 34773379 Free PMC article.
• Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets.
  Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Reina-Couto M, et al. Front Physiol. 2021 Oct 11;12:746494. doi: 10.3389/fphys.2021.746494. eCollection 2021. Front Physiol. 2021. PMID: 34707513 Free PMC article. Review.

References

1. 1. Biochem J. 1990 Feb 1;265(3):621-36 - PubMed
2. 1. Cardiovasc Res. 2000 Jan 14;45(2):428-36 - PubMed
3. 1. Circulation. 1996 Mar 15;93(6):1087-94 - PubMed
4. 1. Blood Coagul Fibrinolysis. 2003 Sep;14(6):515-21 - PubMed
5. 1. Circulation. 1997 Feb 18;95(4):778-81 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer